CClinicalTrials.gg
CompletedNCT01207570Updated Oct 10, 2011Results posted

Endermotherapy for Children With Developmental Disabilities

A Phase 2 interventional study of Endermotherapy and Passive manual stretching in Cerebral Palsy and Developmental Delay, sponsored by The Hong Kong Polytechnic University. Completed at 1 site in Hong Kong. Open to participants aged 2 Years to 6 Years. Per ClinicalTrials.gov, last updated 2011-10-10.

Sponsored by The Hong Kong Polytechnic University · Phase 2, Interventional, and Treatment

Phase
Phase 2
Study type
Interventional
Enrollment
54
Allocation
Randomized
Ages
2 Years to 6 Years
Sex
All
01

Study summary

Children with developmental disabilities often sustain decreased range of motion in their extremities. The decrease in flexibility may be due to neuromuscular disorders such as spasticity or dystonia. Other causes may be imbalance in muscle strength surrounding a joint, leading to inappropriate habitual posture. Over time, muscle contracture may result for those muscle groups that are placed in a shortened position for an extended period of time. The most common site of muscle contractures among these children are gastrocnemius/soleus (lower limbs), and latissimus dorsi muscles (upper limbs). Muscle contractures can lead to further decline in functional abilities. Therefore, it is important to identify effective intervention strategies to enhance or maintain muscle flexibility in children with developmental dysfunctions.

Commercially available endermotherapy device has been used to soften scar tissue following burn injuries. The mechanical stimulation applied may also have beneficial effects on relaxing the muscle tissue. The overall aim of the proposed study is to determine whether endermotherapy treatment has immediate effect in improving joint range of motion among children with developmental disabilities.

The research hypothesis is that children in the endermotherapy group will have significantly more gain in ankle passive range of motion than those in the control group.

02

Conditions studied

  • Cerebral Palsy
  • Developmental Delay

Keywords

  • flexibility
  • muscle
  • stretching
  • cerebral palsy
  • developmental
03

In context

Cerebral Palsy

1,853 studies on the registry are indexed under Cerebral Palsy; 435 are open to participants now.

This study's enrollment of 54 is above the median of 33 across 1,368 interventional studies indexed under Cerebral Palsy.

Browse Cerebral Palsy studies →

Lead sponsor

The Hong Kong Polytechnic University is the lead sponsor of 659 studies on the registry; 250 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
2 Years to 6 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • children aged between 2 and 6.
  • children with diagnosis of cerebral palsy or developmental disabilities.
  • Has limited ankle dorsiflexion range of motion (less than 20 degrees)

Exclusion criteria

Exclusion Criteria:

  • Other serious illnesses that preclude participation
05

Study design

Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Outcomes assessor)
Enrollment
54 participants (actual)

Study arms

  • Experimental
    Endermotherapy

    The subjects in the experimental group will receive a single session (5 minutes) of endermotherapy) applied to the gastrocnemius/soleus muscle group in the more affected side. The treatment will b e carried out by a qualified physiotherapist.

    Procedure: Endermotherapy

  • Active comparator
    Passive stretching

    The subjects in this group will receive a single session of passive stretching of the gastrocnemius/soleus muscle for 5 minutes.

    Procedure: Passive manual stretching

Interventions

  • ProcedureEndermotherapy

    The subjects will receive a single session of endermotherapy applied to the gastrocnemius/soleus muscle on the more affected side for 5 minutes. The treatment will be conducted by a qualified physiotherapist.

  • ProcedurePassive manual stretching

    The subjects will receive a single session of passive manual stretching of the gastrocnemius/soleus muscle on the more affected side. The treatment will be given by a qualified physiotherapist.

06

What researchers measure

Primary outcomes

  1. Ankle Passive Range of Motion

    The ankle passive range of motion will be measured by a Myrin goniometer.

    Time frame: day 1 before treatment

  2. Ankle Passive Range of Motion

    Ankle passive range of motion at day 4 before the crossover treatment

    Time frame: day 4 before treatment

  3. Ankle Passive Range of Motion

    Ankle dorsiflexion passive range of motion

    Time frame: Day 1 after treatment

  4. Ankle Passive Range of Motion

    Ankle passive range of motion on day 4 after the crossover treatment

    Time frame: Day 4 after treatment

07

Results

Posted Sep 13, 2011

Participant flow

The subjects were recruited from Heep Hong Society, a non-governmental organization that provides rehabilitation services for children with disabilities. The recruitment period was between January 2010 and June 2010.

The First Stage (Before Crossover)
Participant flow — The First Stage (Before Crossover)
MilestoneEndermotherapyPassive Stretching
Started2331
Completed2331
Not completed00
The Second Stage (After Crossover)
Participant flow — The Second Stage (After Crossover)
MilestoneEndermotherapyPassive Stretching
Started3123
Completed3123
Not completed00

Outcome measures

PrimaryAnkle Passive Range of Motion

The ankle passive range of motion will be measured by a Myrin goniometer.

Time frame:
day 1 before treatment
Reported as:
Mean · degree
Ankle Passive Range of Motion
degreeEndermotherapyPassive Stretching
Ankle Passive Range of Motion8.3 ± 8.110.4 ± 6.0
PrimaryAnkle Passive Range of Motion

Ankle passive range of motion at day 4 before the crossover treatment

Time frame:
day 4 before treatment
Reported as:
Mean · degree
Ankle Passive Range of Motion
degreeEndermotherapyPassive Stretching
Ankle Passive Range of Motion11.6 ± 6.011.3 ± 8.3
PrimaryAnkle Passive Range of Motion

Ankle dorsiflexion passive range of motion

Time frame:
Day 1 after treatment
Reported as:
Mean · degree
Ankle Passive Range of Motion
degreeEndermotherapyPassive Stretching
Ankle Passive Range of Motion12.2 ± 8.614.9 ± 6.7
PrimaryAnkle Passive Range of Motion

Ankle passive range of motion on day 4 after the crossover treatment

Time frame:
Day 4 after treatment
Reported as:
Mean · degree
Ankle Passive Range of Motion
degreeEndermotherapyPassive Stretching
Ankle Passive Range of Motion15.9 ± 6.713.5 ± 8.4

Adverse events

Non-serious events are listed at a 5% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Endermotherapy—0/54 (0%)0/54 (0%)
Passive Stretching—0/54 (0%)0/54 (0%)

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)EndermotherapyPassive StretchingTotal
<=18 years233154
Between 18 and 65 years000
>=65 years000
Age Continuous
Age Continuous(years)EndermotherapyPassive StretchingTotal
Mean4.7 ± 1.54.9 ± 1.24.8 ± 1.3
Sex: Female, Male
Sex: Female, Male(Participants)EndermotherapyPassive StretchingTotal
Female71522
Male161632
Region of Enrollment
Region of Enrollment(participants)EndermotherapyPassive StretchingTotal
Hong Kong233154
08

Study locations

1 site
  • Heep Hong Society
    Hong Kong, Hong Kong
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 10, 2011, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01207570
Lead sponsor
The Hong Kong Polytechnic University
Collaborators
Phoelia Co. Ltd.
Responsible party
Marco Yiu-Chung Pang (Associate Professor, The Hong Kong Polytechnic University) — Principal investigator
First posted
Sep 23, 2010
Start date
Feb 2010
Primary completion
May 2011
Completion
May 2011
Results posted
Sep 13, 2011
Last update
Oct 10, 2011

Study contacts

Marco Y P, PhD
principal investigator · The Hong Kong Polytechnic University

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2011. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion